NCT03678675View on ClinicalTrials.gov

Increased Ketorolac Administration After Cesarean Section and Its Effect on Opioid Use: a Randomized Control Trial

PHASE3CompletedINTERVENTIONAL
Enrollment

148

Participants

Timeline

Start Date

May 30, 2019

Primary Completion Date

January 31, 2022

Study Completion Date

June 30, 2022

Conditions
Post-operative PainPost-partum PainCesarean Section Complications
Interventions
DRUG

Ketorolac

The intervention is a protocol of scheduled IV Ketorolac administered postoperatively.

Trial Locations (1)

02111

Tufts Medical Center, Boston

All Listed Sponsors
lead

Tufts Medical Center

OTHER

NCT03678675 - Increased Ketorolac Administration After Cesarean Section and Its Effect on Opioid Use: a Randomized Control Trial | Biotech Hunter | Biotech Hunter